MoneyWorks4Me

Jubilant Pharmova informs about completion of USFDA inspection

19 Jun 2026 Evaluate

Jubilant Pharmova has informed that the USFDA has completed an inspection of the Jubilant HollisterStier LLC (‘JHS’) CMO business at Spokane WA, U.S.A facility. The company has enclosed the details regarding the dates of the inspection and outcome of the inspection in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Date and Time of receipt - June 17, 2026, 15:30 PM (PST), June 18, 2026, 04:00 am (IST).

The above information is a part of company’s filings submitted to BSE.


Jubilant Pharmova Share Price

931.75 6.75 (0.73%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: